Pathological Examination Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Pathological Examination market size was valued at USD 29070 million in 2022 and is forecast to a readjusted size of USD 55110 million by 2029 with a CAGR of 9.6% during review period.

A pathomorphological method used to examine pathological changes in organs, tissues or cells. In order to explore the disease process of organs, tissues or cells, some pathomorphological examination method can be used to check the pathological changes, explore the causes, pathogenesis, occurrence and development process of lesions, and finally make pathological diagnosis.

From perspective of type, pathological examination can be split into histopathology, cell pathology, immunohistochemical pathology and molecular pathology. In 2019, cell pathology took up for about 48% market share, which made it the largest segment of global pathological examination. North America is the largest consumption region of pathological examination, with a consumption market share nearly 37% in 2019. The second place is Asia-Pacific; following North America with the consumption market share over 31% in 2020. Key players of global pathological examination market are Quest Diagnostics, Sonic Healthcare, Lab Corp, Unilabs, SYNLAB International. The top 5 players totally took up a market share of about 18% in 2019. Quest Diagnostics is in the first place, which accounted for above 5% of global market.

This report is a detailed and comprehensive analysis for global Pathological Examination market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Pathological Examination market size and forecasts, in consumption value ($ Million), 2018-2029
Global Pathological Examination market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Pathological Examination market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Pathological Examination market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pathological Examination
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Pathological Examination market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   Quest Diagnostics
   Sonic Healthcare
   Lab Corp
   Unilabs
   SYNLAB International
   BML
   Pathologists Diagnostic
   StageBio
   KingMed Diagnostics Group
   Dian Diagnostics Group
   Adicon Clinical Laboratories Inc.
   Huayin Health

   Histopathology
   Cytopathology
   Immunohistochemical Pathology
   Molecular Pathology

   Hospital
   Medical Laboratory

   North America (United States, Canada, and Mexico)
   Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
   South America (Brazil, Argentina and Rest of South America)
   Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

What are the strengths of the pathological examination market in 2025?

The market will benefit from advanced diagnostic technologies like AI-driven tools and automated systems, improving the accuracy and speed of pathology results. Increasing demand for early disease detection and personalized medicine will also drive growth.

What weaknesses are present in the pathological examination market?

High costs of advanced diagnostic tools may limit access, especially in low-resource settings. Additionally, a shortage of skilled pathologists and technical challenges associated with new technologies could hinder market growth.

What opportunities exist for the pathological examination market in 2025?

Opportunities lie in the growing trend of telemedicine and digital pathology, which can enhance access to pathology services globally. There’s also a potential for expansion in emerging markets and the integration of new biomarkers for more personalized diagnostics.

What threats could impact the pathological examination market?

Regulatory challenges, such as the approval of new technologies and reimbursement issues, could slow down market expansion. Additionally, the growing concern over data privacy and cybersecurity risks in digital pathology platforms may pose threats to the industry.

What political factors will impact the pathological examination market in 2025?

Government policies on healthcare funding and reimbursement schemes will play a significant role in market growth. Additionally, regulatory frameworks around the approval of new diagnostic technologies and the implementation of telemedicine policies will be crucial.

How will economic factors influence the pathological examination market?

Economic factors such as healthcare budgets, patient spending power, and the overall economic stability of regions will impact the accessibility of pathological examination services. In emerging markets, economic growth may drive the adoption of advanced diagnostic technologies, while in economically strained regions, cost constraints could limit access to these services.

What social factors are important for the pathological examination market?

An aging population, increasing awareness of preventive healthcare, and rising demand for personalized medicine are key social trends. Furthermore, public attitudes toward data privacy and acceptance of digital pathology platforms will shape the market's growth trajectory.

How will technological advancements affect the pathological examination market?

The integration of AI, machine learning, and automation in pathology will significantly enhance diagnostic accuracy, reduce human error, and improve the efficiency of the examination process. Advancements in digital pathology and telemedicine will further expand access to these services globally.

What environmental factors could influence the pathological examination market?

Sustainability practices, such as reducing waste generated by diagnostic procedures and using eco-friendly materials, will become increasingly important. Additionally, the environmental impact of manufacturing diagnostic equipment could influence companies' strategies and consumer preferences.

What legal factors will affect the pathological examination market?

Stringent regulations around medical device approval, data protection laws (especially regarding patient data), and intellectual property rights related to diagnostic innovations will impact the market. Legal challenges related to malpractice and liability in the use of new technologies could also pose risks.

Who are the suppliers in the pathological examination market in 2025?

Suppliers include manufacturers of diagnostic equipment, technology providers offering AI and automation tools, reagent suppliers, and service providers offering laboratory services. These players provide the essential resources needed for pathological examination processes.

What inputs are required in the pathological examination market?

Inputs include patient samples (such as blood, tissue, or bodily fluids), diagnostic technologies (e.g., microscopes, AI-driven software), reagents, and skilled professionals (pathologists, laboratory technicians) who perform the analysis.

What process steps are involved in pathological examination?

The process steps include sample collection, transportation, preparation, examination (microscopic or digital), data analysis using diagnostic technologies, and reporting of findings to healthcare providers or patients.

Who are the customers in the pathological examination market?

Customers include healthcare providers (hospitals, clinics), diagnostic labs, pharmaceutical companies, and research organizations. Ultimately, patients also represent a key customer group, as they rely on accurate pathology results for treatment decisions.

What are the outputs in the pathological examination market?

Outputs include pathology reports, diagnostic results, recommendations for treatment or further testing, and sometimes digital images or data that contribute to ongoing medical research or patient care.

What is the threat of new entrants in the pathological examination market in 2025?

The threat of new entrants is moderate. While the demand for pathology services is growing, the market requires substantial investment in advanced technologies, skilled labor, and regulatory compliance, which can create significant barriers to entry.

How intense is the bargaining power of suppliers in the pathological examination market?

The bargaining power of suppliers is moderate to high. Key suppliers, including diagnostic technology manufacturers and reagent providers, hold significant influence due to the specialized nature of their products and limited competition in certain advanced technologies.

What is the bargaining power of buyers in the pathological examination market?

The bargaining power of buyers is moderate. While healthcare providers and patients have choices, the specialized nature of pathology services and the reliance on accurate results mean that patients and healthcare organizations are often dependent on established providers for trusted results.

What is the threat of substitutes in the pathological examination market?

The threat of substitutes is low to moderate. While advancements in imaging technologies and genetic testing provide alternative diagnostic routes, they are often complementary rather than substitutes. Pathological examinations remain essential for confirming diagnoses in many cases.

How competitive is the pathological examination market?

The market is moderately competitive. There are a few dominant players in terms of advanced diagnostic technologies, but many regional and local providers also compete for market share, creating a balance between large firms and smaller, specialized laboratories.

What are the key upstream factors impacting the pathological examination market in 2025?

Key upstream factors include the availability and cost of raw materials for diagnostic tools, such as reagents and imaging devices, as well as the development and production of advanced technologies like AI and automation systems for pathology.

How do suppliers of diagnostic equipment and reagents influence the market?

Suppliers of diagnostic equipment and reagents have significant influence, as they provide the critical inputs required for performing pathology exams. Innovations, cost fluctuations, and supply chain issues among these suppliers can directly impact the pricing and accessibility of services.

What role do research and development (R&D) efforts play in the upstream market?

R&D efforts are crucial, as they drive innovation in diagnostic tools, technologies, and techniques. Ongoing development of digital pathology, AI, and personalized medicine solutions can revolutionize the market by improving accuracy, speed, and cost-effectiveness in examinations.

How does the regulatory environment affect the upstream factors in the pathological examination market?

The regulatory environment significantly impacts upstream factors by determining the approval processes for diagnostic equipment, reagents, and technologies. Stringent regulatory requirements can delay the introduction of new products, while favorable policies can accelerate innovation and market growth.

What impact do raw material shortages or supply chain disruptions have on the market?

Shortages of key raw materials, such as reagents or components for diagnostic machines, can disrupt the entire supply chain, affecting the timely delivery of services. Supply chain disruptions can also drive up costs, making pathology services less affordable or less accessible in certain regions.

What are the key midstream activities in the pathological examination market in 2025?

Key midstream activities involve the actual process of sample collection, preparation, analysis, and reporting. This includes laboratory operations, quality control, data interpretation, and the integration of advanced diagnostic tools like AI and machine learning for more accurate results.

How do laboratories and healthcare providers influence the market?

Laboratories and healthcare providers are central to the midstream process as they facilitate the actual testing and diagnostic procedures. Their efficiency, technological adoption, and ability to meet regulatory standards play a vital role in the speed, quality, and accessibility of pathological examinations.

What role does technology integration play in the midstream market?

Technology integration, especially in areas like digital pathology, automation, and AI-driven diagnostics, is transforming midstream operations. These innovations streamline workflow, enhance diagnostic accuracy, and improve turnaround times, benefiting both healthcare providers and patients.

How does the workforce in pathology influence the midstream market?

The skilled workforce, including pathologists, lab technicians, and support staff, directly affects the quality and efficiency of midstream operations. Shortages of trained professionals or inefficiencies in labor utilization can lead to delays and compromise diagnostic outcomes.

What challenges do laboratories face in the midstream process?

Laboratories often face challenges such as high operational costs, maintaining quality control, keeping up with evolving technologies, and managing large volumes of samples. Regulatory compliance and ensuring data security are also significant concerns as digital pathology grows in prominence.

What are the key downstream activities in the pathological examination market in 2025?

Key downstream activities include the delivery of diagnostic results to healthcare providers, patient consultations, treatment decisions, and follow-up care. This also involves the communication of pathology reports, integration with patient records, and providing guidance for further testing or therapies.

How do healthcare providers and patients influence the downstream market?

Healthcare providers and patients are the primary recipients of the pathology services. The demand for timely, accurate results influences the quality and speed of the diagnostic process. Additionally, the adoption of personalized medicine and telemedicine are pushing for more integrated and patient-centric downstream services.

What role do insurance and reimbursement policies play in the downstream market?

Insurance and reimbursement policies are crucial in determining the affordability and accessibility of pathology services for patients. Favorable reimbursement rates encourage healthcare providers to offer a wider range of diagnostic services, while restrictive policies could limit access, especially in underinsured populations.

How does patient access to pathology services impact the downstream market?

Patient access to pathology services directly impacts the downstream market’s growth. Factors such as geographic location, healthcare infrastructure, affordability, and health literacy determine how easily patients can receive diagnostic tests and follow-up care, influencing overall demand.

What are the challenges in the downstream process of the pathological examination market?

Challenges in the downstream process include delayed reporting, issues with data interoperability, and the need for more personalized post-examination care. Additionally, ensuring that patients understand and act on their pathology results remains a significant challenge for healthcare providers.

Chapter 1, to describe Pathological Examination product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pathological Examination, with revenue, gross margin and global market share of Pathological Examination from 2018 to 2023.
Chapter 3, the Pathological Examination competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Pathological Examination market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Pathological Examination.
Chapter 13, to describe Pathological Examination research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Pathological Examination
   1.2 Market Estimation Caveats and Base Year
   1.3 Classification of Pathological Examination by Type
       1.3.1 Overview: Global Pathological Examination Market Size by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Global Pathological Examination Consumption Value Market Share by Type in 2022
       1.3.3 Histopathology
       1.3.4 Cytopathology
       1.3.5 Immunohistochemical Pathology
       1.3.6 Molecular Pathology
   1.4 Global Pathological Examination Market by Application
       1.4.1 Overview: Global Pathological Examination Market Size by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Hospital
       1.4.3 Medical Laboratory
   1.5 Global Pathological Examination Market Size & Forecast
   1.6 Global Pathological Examination Market Size and Forecast by Region
       1.6.1 Global Pathological Examination Market Size by Region: 2018 VS 2022 VS 2029
       1.6.2 Global Pathological Examination Market Size by Region, (2018-2029)
       1.6.3 North America Pathological Examination Market Size and Prospect (2018-2029)
       1.6.4 Europe Pathological Examination Market Size and Prospect (2018-2029)
       1.6.5 Asia-Pacific Pathological Examination Market Size and Prospect (2018-2029)
       1.6.6 South America Pathological Examination Market Size and Prospect (2018-2029)
       1.6.7 Middle East and Africa Pathological Examination Market Size and Prospect (2018-2029)

2 Company Profiles

   2.1 Quest Diagnostics
       2.1.1 Quest Diagnostics Details
       2.1.2 Quest Diagnostics Major Business
       2.1.3 Quest Diagnostics Pathological Examination Product and Solutions
       2.1.4 Quest Diagnostics Pathological Examination Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Quest Diagnostics Recent Developments and Future Plans
   2.2 Sonic Healthcare
       2.2.1 Sonic Healthcare Details
       2.2.2 Sonic Healthcare Major Business
       2.2.3 Sonic Healthcare Pathological Examination Product and Solutions
       2.2.4 Sonic Healthcare Pathological Examination Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Sonic Healthcare Recent Developments and Future Plans
   2.3 Lab Corp
       2.3.1 Lab Corp Details
       2.3.2 Lab Corp Major Business
       2.3.3 Lab Corp Pathological Examination Product and Solutions
       2.3.4 Lab Corp Pathological Examination Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Lab Corp Recent Developments and Future Plans
   2.4 Unilabs
       2.4.1 Unilabs Details
       2.4.2 Unilabs Major Business
       2.4.3 Unilabs Pathological Examination Product and Solutions
       2.4.4 Unilabs Pathological Examination Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Unilabs Recent Developments and Future Plans
   2.5 SYNLAB International
       2.5.1 SYNLAB International Details
       2.5.2 SYNLAB International Major Business
       2.5.3 SYNLAB International Pathological Examination Product and Solutions
       2.5.4 SYNLAB International Pathological Examination Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 SYNLAB International Recent Developments and Future Plans
   2.6 BML
       2.6.1 BML Details
       2.6.2 BML Major Business
       2.6.3 BML Pathological Examination Product and Solutions
       2.6.4 BML Pathological Examination Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 BML Recent Developments and Future Plans
   2.7 Pathologists Diagnostic
       2.7.1 Pathologists Diagnostic Details
       2.7.2 Pathologists Diagnostic Major Business
       2.7.3 Pathologists Diagnostic Pathological Examination Product and Solutions
       2.7.4 Pathologists Diagnostic Pathological Examination Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Pathologists Diagnostic Recent Developments and Future Plans
   2.8 StageBio
       2.8.1 StageBio Details
       2.8.2 StageBio Major Business
       2.8.3 StageBio Pathological Examination Product and Solutions
       2.8.4 StageBio Pathological Examination Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 StageBio Recent Developments and Future Plans
   2.9 KingMed Diagnostics Group
       2.9.1 KingMed Diagnostics Group Details
       2.9.2 KingMed Diagnostics Group Major Business
       2.9.3 KingMed Diagnostics Group Pathological Examination Product and Solutions
       2.9.4 KingMed Diagnostics Group Pathological Examination Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 KingMed Diagnostics Group Recent Developments and Future Plans
   2.10 Dian Diagnostics Group 
       2.10.1 Dian Diagnostics Group Details
       2.10.2 Dian Diagnostics Group Major Business
       2.10.3 Dian Diagnostics Group Pathological Examination Product and Solutions
       2.10.4 Dian Diagnostics Group Pathological Examination Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 Dian Diagnostics Group Recent Developments and Future Plans
   2.11 Adicon Clinical Laboratories Inc.
       2.11.1 Adicon Clinical Laboratories Inc. Details
       2.11.2 Adicon Clinical Laboratories Inc. Major Business
       2.11.3 Adicon Clinical Laboratories Inc. Pathological Examination Product and Solutions
       2.11.4 Adicon Clinical Laboratories Inc. Pathological Examination Revenue, Gross Margin and Market Share (2018-2023)
       2.11.5 Adicon Clinical Laboratories Inc. Recent Developments and Future Plans
   2.12 Huayin Health
       2.12.1 Huayin Health Details
       2.12.2 Huayin Health Major Business
       2.12.3 Huayin Health Pathological Examination Product and Solutions
       2.12.4 Huayin Health Pathological Examination Revenue, Gross Margin and Market Share (2018-2023)
       2.12.5 Huayin Health Recent Developments and Future Plans

3 Market Competition, by Players

   3.1 Global Pathological Examination Revenue and Share by Players (2018-2023)
   3.2 Market Share Analysis (2022)
       3.2.1 Market Share of Pathological Examination by Company Revenue
       3.2.2 Top 3 Pathological Examination Players Market Share in 2022
       3.2.3 Top 6 Pathological Examination Players Market Share in 2022
   3.3 Pathological Examination Market: Overall Company Footprint Analysis
       3.3.1 Pathological Examination Market: Region Footprint
       3.3.2 Pathological Examination Market: Company Product Type Footprint
       3.3.3 Pathological Examination Market: Company Product Application Footprint
   3.4 New Market Entrants and Barriers to Market Entry
   3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

   4.1 Global Pathological Examination Consumption Value and Market Share by Type (2018-2023)
   4.2 Global Pathological Examination Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

   5.1 Global Pathological Examination Consumption Value Market Share by Application (2018-2023)
   5.2 Global Pathological Examination Market Forecast by Application (2024-2029)

6 North America

   6.1 North America Pathological Examination Consumption Value by Type (2018-2029)
   6.2 North America Pathological Examination Consumption Value by Application (2018-2029)
   6.3 North America Pathological Examination Market Size by Country
       6.3.1 North America Pathological Examination Consumption Value by Country (2018-2029)
       6.3.2 United States Pathological Examination Market Size and Forecast (2018-2029)
       6.3.3 Canada Pathological Examination Market Size and Forecast (2018-2029)
       6.3.4 Mexico Pathological Examination Market Size and Forecast (2018-2029)

7 Europe

   7.1 Europe Pathological Examination Consumption Value by Type (2018-2029)
   7.2 Europe Pathological Examination Consumption Value by Application (2018-2029)
   7.3 Europe Pathological Examination Market Size by Country
       7.3.1 Europe Pathological Examination Consumption Value by Country (2018-2029)
       7.3.2 Germany Pathological Examination Market Size and Forecast (2018-2029)
       7.3.3 France Pathological Examination Market Size and Forecast (2018-2029)
       7.3.4 United Kingdom Pathological Examination Market Size and Forecast (2018-2029)
       7.3.5 Russia Pathological Examination Market Size and Forecast (2018-2029)
       7.3.6 Italy Pathological Examination Market Size and Forecast (2018-2029)

8 Asia-Pacific

   8.1 Asia-Pacific Pathological Examination Consumption Value by Type (2018-2029)
   8.2 Asia-Pacific Pathological Examination Consumption Value by Application (2018-2029)
   8.3 Asia-Pacific Pathological Examination Market Size by Region
       8.3.1 Asia-Pacific Pathological Examination Consumption Value by Region (2018-2029)
       8.3.2 China Pathological Examination Market Size and Forecast (2018-2029)
       8.3.3 Japan Pathological Examination Market Size and Forecast (2018-2029)
       8.3.4 South Korea Pathological Examination Market Size and Forecast (2018-2029)
       8.3.5 India Pathological Examination Market Size and Forecast (2018-2029)
       8.3.6 Southeast Asia Pathological Examination Market Size and Forecast (2018-2029)
       8.3.7 Australia Pathological Examination Market Size and Forecast (2018-2029)

9 South America

   9.1 South America Pathological Examination Consumption Value by Type (2018-2029)
   9.2 South America Pathological Examination Consumption Value by Application (2018-2029)
   9.3 South America Pathological Examination Market Size by Country
       9.3.1 South America Pathological Examination Consumption Value by Country (2018-2029)
       9.3.2 Brazil Pathological Examination Market Size and Forecast (2018-2029)
       9.3.3 Argentina Pathological Examination Market Size and Forecast (2018-2029)

10 Middle East & Africa

   10.1 Middle East & Africa Pathological Examination Consumption Value by Type (2018-2029)
   10.2 Middle East & Africa Pathological Examination Consumption Value by Application (2018-2029)
   10.3 Middle East & Africa Pathological Examination Market Size by Country
       10.3.1 Middle East & Africa Pathological Examination Consumption Value by Country (2018-2029)
       10.3.2 Turkey Pathological Examination Market Size and Forecast (2018-2029)
       10.3.3 Saudi Arabia Pathological Examination Market Size and Forecast (2018-2029)
       10.3.4 UAE Pathological Examination Market Size and Forecast (2018-2029)

11 Market Dynamics

   11.1 Pathological Examination Market Drivers
   11.2 Pathological Examination Market Restraints
   11.3 Pathological Examination Trends Analysis
   11.4 Porters Five Forces Analysis
       11.4.1 Threat of New Entrants
       11.4.2 Bargaining Power of Suppliers
       11.4.3 Bargaining Power of Buyers
       11.4.4 Threat of Substitutes
       11.4.5 Competitive Rivalry
   11.5 Influence of COVID-19 and Russia-Ukraine War
       11.5.1 Influence of COVID-19
       11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

   12.1 Pathological Examination Industry Chain
   12.2 Pathological Examination Upstream Analysis
   12.3 Pathological Examination Midstream Analysis
   12.4 Pathological Examination Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

   14.1 Methodology
   14.2 Research Process and Data Source
   14.3 Disclaimer

List of Tables

   Table 1. Global Pathological Examination Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Pathological Examination Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Global Pathological Examination Consumption Value by Region (2018-2023) & (USD Million)
   Table 4. Global Pathological Examination Consumption Value by Region (2024-2029) & (USD Million)
   Table 5. Quest Diagnostics Company Information, Head Office, and Major Competitors
   Table 6. Quest Diagnostics Major Business
   Table 7. Quest Diagnostics Pathological Examination Product and Solutions
   Table 8. Quest Diagnostics Pathological Examination Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 9. Quest Diagnostics Recent Developments and Future Plans
   Table 10. Sonic Healthcare Company Information, Head Office, and Major Competitors
   Table 11. Sonic Healthcare Major Business
   Table 12. Sonic Healthcare Pathological Examination Product and Solutions
   Table 13. Sonic Healthcare Pathological Examination Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 14. Sonic Healthcare Recent Developments and Future Plans
   Table 15. Lab Corp Company Information, Head Office, and Major Competitors
   Table 16. Lab Corp Major Business
   Table 17. Lab Corp Pathological Examination Product and Solutions
   Table 18. Lab Corp Pathological Examination Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 19. Lab Corp Recent Developments and Future Plans
   Table 20. Unilabs Company Information, Head Office, and Major Competitors
   Table 21. Unilabs Major Business
   Table 22. Unilabs Pathological Examination Product and Solutions
   Table 23. Unilabs Pathological Examination Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 24. Unilabs Recent Developments and Future Plans
   Table 25. SYNLAB International Company Information, Head Office, and Major Competitors
   Table 26. SYNLAB International Major Business
   Table 27. SYNLAB International Pathological Examination Product and Solutions
   Table 28. SYNLAB International Pathological Examination Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 29. SYNLAB International Recent Developments and Future Plans
   Table 30. BML Company Information, Head Office, and Major Competitors
   Table 31. BML Major Business
   Table 32. BML Pathological Examination Product and Solutions
   Table 33. BML Pathological Examination Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 34. BML Recent Developments and Future Plans
   Table 35. Pathologists Diagnostic Company Information, Head Office, and Major Competitors
   Table 36. Pathologists Diagnostic Major Business
   Table 37. Pathologists Diagnostic Pathological Examination Product and Solutions
   Table 38. Pathologists Diagnostic Pathological Examination Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 39. Pathologists Diagnostic Recent Developments and Future Plans
   Table 40. StageBio Company Information, Head Office, and Major Competitors
   Table 41. StageBio Major Business
   Table 42. StageBio Pathological Examination Product and Solutions
   Table 43. StageBio Pathological Examination Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 44. StageBio Recent Developments and Future Plans
   Table 45. KingMed Diagnostics Group Company Information, Head Office, and Major Competitors
   Table 46. KingMed Diagnostics Group Major Business
   Table 47. KingMed Diagnostics Group Pathological Examination Product and Solutions
   Table 48. KingMed Diagnostics Group Pathological Examination Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 49. KingMed Diagnostics Group Recent Developments and Future Plans
   Table 50. Dian Diagnostics Group Company Information, Head Office, and Major Competitors
   Table 51. Dian Diagnostics Group Major Business
   Table 52. Dian Diagnostics Group Pathological Examination Product and Solutions
   Table 53. Dian Diagnostics Group Pathological Examination Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 54. Dian Diagnostics Group Recent Developments and Future Plans
   Table 55. Adicon Clinical Laboratories Inc. Company Information, Head Office, and Major Competitors
   Table 56. Adicon Clinical Laboratories Inc. Major Business
   Table 57. Adicon Clinical Laboratories Inc. Pathological Examination Product and Solutions
   Table 58. Adicon Clinical Laboratories Inc. Pathological Examination Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 59. Adicon Clinical Laboratories Inc. Recent Developments and Future Plans
   Table 60. Huayin Health Company Information, Head Office, and Major Competitors
   Table 61. Huayin Health Major Business
   Table 62. Huayin Health Pathological Examination Product and Solutions
   Table 63. Huayin Health Pathological Examination Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 64. Huayin Health Recent Developments and Future Plans
   Table 65. Global Pathological Examination Revenue (USD Million) by Players (2018-2023)
   Table 66. Global Pathological Examination Revenue Share by Players (2018-2023)
   Table 67. Breakdown of Pathological Examination by Company Type (Tier 1, Tier 2, and Tier 3)
   Table 68. Market Position of Players in Pathological Examination, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
   Table 69. Head Office of Key Pathological Examination Players
   Table 70. Pathological Examination Market: Company Product Type Footprint
   Table 71. Pathological Examination Market: Company Product Application Footprint
   Table 72. Pathological Examination New Market Entrants and Barriers to Market Entry
   Table 73. Pathological Examination Mergers, Acquisition, Agreements, and Collaborations
   Table 74. Global Pathological Examination Consumption Value (USD Million) by Type (2018-2023)
   Table 75. Global Pathological Examination Consumption Value Share by Type (2018-2023)
   Table 76. Global Pathological Examination Consumption Value Forecast by Type (2024-2029)
   Table 77. Global Pathological Examination Consumption Value by Application (2018-2023)
   Table 78. Global Pathological Examination Consumption Value Forecast by Application (2024-2029)
   Table 79. North America Pathological Examination Consumption Value by Type (2018-2023) & (USD Million)
   Table 80. North America Pathological Examination Consumption Value by Type (2024-2029) & (USD Million)
   Table 81. North America Pathological Examination Consumption Value by Application (2018-2023) & (USD Million)
   Table 82. North America Pathological Examination Consumption Value by Application (2024-2029) & (USD Million)
   Table 83. North America Pathological Examination Consumption Value by Country (2018-2023) & (USD Million)
   Table 84. North America Pathological Examination Consumption Value by Country (2024-2029) & (USD Million)
   Table 85. Europe Pathological Examination Consumption Value by Type (2018-2023) & (USD Million)
   Table 86. Europe Pathological Examination Consumption Value by Type (2024-2029) & (USD Million)
   Table 87. Europe Pathological Examination Consumption Value by Application (2018-2023) & (USD Million)
   Table 88. Europe Pathological Examination Consumption Value by Application (2024-2029) & (USD Million)
   Table 89. Europe Pathological Examination Consumption Value by Country (2018-2023) & (USD Million)
   Table 90. Europe Pathological Examination Consumption Value by Country (2024-2029) & (USD Million)
   Table 91. Asia-Pacific Pathological Examination Consumption Value by Type (2018-2023) & (USD Million)
   Table 92. Asia-Pacific Pathological Examination Consumption Value by Type (2024-2029) & (USD Million)
   Table 93. Asia-Pacific Pathological Examination Consumption Value by Application (2018-2023) & (USD Million)
   Table 94. Asia-Pacific Pathological Examination Consumption Value by Application (2024-2029) & (USD Million)
   Table 95. Asia-Pacific Pathological Examination Consumption Value by Region (2018-2023) & (USD Million)
   Table 96. Asia-Pacific Pathological Examination Consumption Value by Region (2024-2029) & (USD Million)
   Table 97. South America Pathological Examination Consumption Value by Type (2018-2023) & (USD Million)
   Table 98. South America Pathological Examination Consumption Value by Type (2024-2029) & (USD Million)
   Table 99. South America Pathological Examination Consumption Value by Application (2018-2023) & (USD Million)
   Table 100. South America Pathological Examination Consumption Value by Application (2024-2029) & (USD Million)
   Table 101. South America Pathological Examination Consumption Value by Country (2018-2023) & (USD Million)
   Table 102. South America Pathological Examination Consumption Value by Country (2024-2029) & (USD Million)
   Table 103. Middle East & Africa Pathological Examination Consumption Value by Type (2018-2023) & (USD Million)
   Table 104. Middle East & Africa Pathological Examination Consumption Value by Type (2024-2029) & (USD Million)
   Table 105. Middle East & Africa Pathological Examination Consumption Value by Application (2018-2023) & (USD Million)
   Table 106. Middle East & Africa Pathological Examination Consumption Value by Application (2024-2029) & (USD Million)
   Table 107. Middle East & Africa Pathological Examination Consumption Value by Country (2018-2023) & (USD Million)
   Table 108. Middle East & Africa Pathological Examination Consumption Value by Country (2024-2029) & (USD Million)
   Table 109. Pathological Examination Raw Material
   Table 110. Key Suppliers of Pathological Examination Raw Materials

List of Figures

   Figure 1. Pathological Examination Picture
   Figure 2. Global Pathological Examination Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Pathological Examination Consumption Value Market Share by Type in 2022
   Figure 4. Histopathology
   Figure 5. Cytopathology
   Figure 6. Immunohistochemical Pathology
   Figure 7. Molecular Pathology
   Figure 8. Global Pathological Examination Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 9. Pathological Examination Consumption Value Market Share by Application in 2022
   Figure 10. Hospital Picture
   Figure 11. Medical Laboratory Picture
   Figure 12. Global Pathological Examination Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 13. Global Pathological Examination Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 14. Global Market Pathological Examination Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
   Figure 15. Global Pathological Examination Consumption Value Market Share by Region (2018-2029)
   Figure 16. Global Pathological Examination Consumption Value Market Share by Region in 2022
   Figure 17. North America Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 18. Europe Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 19. Asia-Pacific Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 20. South America Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 21. Middle East and Africa Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 22. Global Pathological Examination Revenue Share by Players in 2022
   Figure 23. Pathological Examination Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
   Figure 24. Global Top 3 Players Pathological Examination Market Share in 2022
   Figure 25. Global Top 6 Players Pathological Examination Market Share in 2022
   Figure 26. Global Pathological Examination Consumption Value Share by Type (2018-2023)
   Figure 27. Global Pathological Examination Market Share Forecast by Type (2024-2029)
   Figure 28. Global Pathological Examination Consumption Value Share by Application (2018-2023)
   Figure 29. Global Pathological Examination Market Share Forecast by Application (2024-2029)
   Figure 30. North America Pathological Examination Consumption Value Market Share by Type (2018-2029)
   Figure 31. North America Pathological Examination Consumption Value Market Share by Application (2018-2029)
   Figure 32. North America Pathological Examination Consumption Value Market Share by Country (2018-2029)
   Figure 33. United States Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 34. Canada Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 35. Mexico Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 36. Europe Pathological Examination Consumption Value Market Share by Type (2018-2029)
   Figure 37. Europe Pathological Examination Consumption Value Market Share by Application (2018-2029)
   Figure 38. Europe Pathological Examination Consumption Value Market Share by Country (2018-2029)
   Figure 39. Germany Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 40. France Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 41. United Kingdom Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 42. Russia Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 43. Italy Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 44. Asia-Pacific Pathological Examination Consumption Value Market Share by Type (2018-2029)
   Figure 45. Asia-Pacific Pathological Examination Consumption Value Market Share by Application (2018-2029)
   Figure 46. Asia-Pacific Pathological Examination Consumption Value Market Share by Region (2018-2029)
   Figure 47. China Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 48. Japan Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 49. South Korea Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 50. India Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 51. Southeast Asia Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 52. Australia Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 53. South America Pathological Examination Consumption Value Market Share by Type (2018-2029)
   Figure 54. South America Pathological Examination Consumption Value Market Share by Application (2018-2029)
   Figure 55. South America Pathological Examination Consumption Value Market Share by Country (2018-2029)
   Figure 56. Brazil Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 57. Argentina Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 58. Middle East and Africa Pathological Examination Consumption Value Market Share by Type (2018-2029)
   Figure 59. Middle East and Africa Pathological Examination Consumption Value Market Share by Application (2018-2029)
   Figure 60. Middle East and Africa Pathological Examination Consumption Value Market Share by Country (2018-2029)
   Figure 61. Turkey Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 62. Saudi Arabia Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 63. UAE Pathological Examination Consumption Value (2018-2029) & (USD Million)
   Figure 64. Pathological Examination Market Drivers
   Figure 65. Pathological Examination Market Restraints
   Figure 66. Pathological Examination Market Trends
   Figure 67. Porters Five Forces Analysis
   Figure 68. Manufacturing Cost Structure Analysis of Pathological Examination in 2022
   Figure 69. Manufacturing Process Analysis of Pathological Examination
   Figure 70. Pathological Examination Industrial Chain
   Figure 71. Methodology
   Figure 72. Research Process and Data Source